Award-winning journalist Patti Neighmond is NPR’s health policy correspondent. Her reports air regularly on NPR newsmagazines All Things Considered, Morning Edition and Weekend Edition.
Patti reported about DES on August 08, 2006, following a “new” study showing that daughters of women who took the anti-miscarriage drug DES, a synthetic estrogen, have a higher risk of developing breast cancer after age 50.
Click here to listen to All Things Considered radio show.
Click here to read the story.
DES and Breast Cancer
- Breast Cancer Screening in Women exposed in Utero to DiEthylStilbestrol.
- Prenatal DiEthylStilbestrol Exposure and Risk of Breast Cancer.
- Risk of Breast Cancer in Women exposed to DiEthylStilbestrol in Utero.
More DES DiEthylStilbestrol Resources
- DES studies on cancers and screening.
- DES studies on epigenetics and transgenerational effects.
- DES studies on fertility and pregnancy.
- DES studies on gender identity and psychological health.
- DES studies on in-utero exposure to DES and side-effects.
- DES studies on the genital tract.
- Papers on DES lawsuits.
- DES videos and posts tagged DES, the DES-exposed, DES victims.